Skip to main content

Table 3 Factors associated with anti-hypertensive therapeutic inertia

From: Is therapeutic inertia present in hyperglycaemia, hypertension and hypercholesterolaemia management among adults with type 2 diabetes in three health clinics in Malaysia? a retrospective cohort study

Parameter

Crude Odd Ratio

(95% CI)

P value

Adjusted Odd Ratio

(95% CI)

P value

Anti-hypertensive therapeutic inertia,n = 281

At least 2 consecutive BP ≥ 140/90 mmHg in the whole 2015 (Noa)

 Yes

0.33 (0.23, 0.47)

 < 0.001

0.28 (0.16, 0.50)

 < 0.001

Health clinic (Seri Kembangana)

 Dengkil

4.09 (2.29, 7.31)

 < 0.001

4.79 (2.03, 11.27)

 < 0.001

 Salak

1.75 (1.19, 2.58)

0.004

1.55 (0.71, 1.00)

0.272

Age in year

0.96 (0.94, 0.98)

 < 0.001

0.97 (0.93, 1.00)

0.054

Ethnicity (Malaya)

 Chinese

0.61 (0.40, 0.93)

0.022

0.63 (0.30, 1.32)

0.222

 Indian

1.38 (0.88, 2.18)

0.163

1.03 (0.46, 2.28)

0.946

Employment status (Employeda)

 Unemployed

0.70 (0.46, 1.08)

0.104

1.48 (0.72, 3.06)

0.287

 Retired/house wife

0.49 (0.32, 0.76)

0.001

1.03 (0.48, 2.22)

0.944

Life event in the past 6 months (Noa)

 Yes

0.64 (0.35, 1.18)

0.151

1.01 (0.47, 2.16)

0.988

Diabetes complications (Noa)

 Diabetes complications (Yes)

0.69 (0.41, 1.16)

0.162

1.05 (0.40, 2.80)

0.917

Hypertension status (Noa)

 Yes

0.48 (0.30, 0.77)

0.003

0.56 (0.22, 1.40)

0.214

Diabetes Duration in year

0.95 (0.92, 0.98)

0.002

1.01 (0.95, 1.06)

0.860

Hypertension Duration in year

0.96 (0.93, 0.99)

0.007

0.99 (0.94, 1.05)

0.750

  1. BP Blood pressure, CI Confidence interval
  2. aReferent group
  3. Nagelkerke R Square for this model is 0.28